Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-05

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approves the original (ANDA) application for Dexmethylphenidate hydrochloride from Amneal Pharmaceuticals of New York LLC (generic ADHD treatment).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)